#United States #healthcare #Biopharma #Morrisville #Valeris

Valeris Achieves Remarkable Growth and Milestones

Valeris, a fully integrated life sciences commercialization partner, recently released its financial results for fiscal year 2025, showcasing impressive growth and the achievement of significant milestones. The company has positioned itself as a key player in US Market Access and Patient Services for biopharmaceutical firms, reinforcing its commitment to solving crucial challenges faced by patients in accessing therapies.

Strong Financial Performance and Integration Success

2025 was a breakout year for Valeris, as it surpassed its financial and sales goals from the outset. This success is reflected in the strong performance of its Patient Support Services, which played a critical role in securing more than 20 new partnerships. Valeris was formed in part through the merger of Mercalis and PharmaCord, completed on May 27, 2025. This merger united patient support expertise with advanced technology and experienced commercial teams, creating an integrated ecosystem primed to address the complexities of patient access and commercialization.

CEO Rob Truckenmiller emphasized that their integrated model is a driving force behind their successes, stating that it benefits both patients and healthcare brands. As Valeris moves into 2026, the company is committed to enhancing its capabilities and partnerships, ultimately aiming to assist the 500 biopharma brands they serve with navigating the complexities of the market.

Strategic Hiring Enhances Leadership

In addition to its financial achievements, Valeris reinforced its leadership team with several strategic hires. The appointments include Jodi Dickinson as Chief People Officer (CPO) and Peter Formisano as Chief Operating Officer (COO), both of whom bring extensive experience in human resources and operational excellence, respectively. Manish Goel was appointed Chief Technology Officer (CTO), focusing on innovation and technology-driven solutions aimed at improving patient outcomes.

Innovative Investments Set the Stage for Future Growth

Valeris' proactive approach towards innovation is evident through its substantial investments in new product initiatives. With plans to enhance its operational efficiency and scalability, Valeris aims to deliver cutting-edge services including Expanded eServices, Digital Patient Engagement, and advanced pharmacy-based solutions. These innovations and investments will not only enhance patient experiences but also allow Valeris to adapt swiftly to changing market dynamics, solidifying its position as a leader in life sciences commercialization.

Strong Performance in Advisory Services

Valeris’ Market Access and Advisory Services segment also reported a commendable performance in 2025. With nearly 50 client partnerships and over 150 engagements, this segment saw the addition of more than 20 new client relationships. The Policy Reporter division likewise experienced significant growth, achieving over a 20% increase in annual revenue while expanding its capabilities to better serve existing and new clients.

Looking Ahead to 2026 and Beyond

As Valeris enters 2026, its key focus remains on scaling beyond the integration phase. The company is dedicated to ongoing investments in technology innovation and responsible AI applications, all aimed at improving patient access and support. Valeris plans to further enhance its integrated approach to delivering data, technology, and services throughout commercialization, thereby optimizing market efficiency for its life sciences partners.

"Integration was the starting point — growth is the mandate," Truckenmiller remarked, articulating Valeris's strategic goals as it navigates into a future marked by precision and impact. This commitment to outcomes-oriented practices emphasizes the importance of enhancing both patient and brand experiences in the healthcare ecosystem.

In Summary

With proven expertise and a comprehensive suite of solutions, Valeris stands at the forefront of life sciences commercialization, helping numerous biopharma companies successfully navigate the complexities of the healthcare landscape. Through continued innovation, strategic partnerships, and a focus on data security, Valeris is well-equipped to improve patient access and therapy adherence, ensuring a positive impact in healthcare for years to come. Valeris is headquartered in Morrisville, North Carolina, with additional offices in Jeffersonville, Indiana. For more information, visit Valeris.com.